Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

• Status: Unknown status
• Trial end date: 2019-11-30
• Target enrollment: 0
• Participant gender: All

Summary

This purpose of this study is to evaluate effect of high-dose Pitavastatin on glucose control in patients with metabolic syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: JW Pharmaceutical
• Treatments: Atorvastatin; Atorvastatin Calcium; Pitavastatin

Criteria

Inclusion Criteria:

• Patients diagnosed as metabolic syndrome according to National cholesterol Education Program criteria

• Patients with hypercholesterolemia who required to start statin therapy

Exclusion Criteria:

• overt diabetes

• acute coronary syndrome within 2 months

• acute cerebrovascular event within 2 months

• recent treatment of statin within 1month

• recent diagnosed neoplasm

• recent diagnosed liver disease

• chronic kidney disease

• patients with myopathy

• pregnant women, nursing mothers, women with possibility of pregnant

• patients being adminstered cyclosporine

• patients with genetic disease such as galactose intolerance, lactose intolerance, glucose-galactose malabsorption

• patients with treatment cyclosporin